Has David Camarata, MD received payments from drug or device companies?

Yes. Drug and device makers reported $406,058 in general payments to David Camarata, MD across 315 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean David Camarata, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about David Camarata, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

David Camarata, MD

Orthopaedic Surgery · Scottsdale, AZNPI 1639128002

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $280,313 of the $406,058 with a category attached, or 69.0%. 31 manufacturers reported payments, led by Lima USA, Inc. at 32.2% of the total. Reporting peaked in 2019 at $216,520 and has fallen 99.8% since, to $380 in 2025. Among orthopaedic surgery clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$406,058in general payments, 2019–2025

Across 315 payments — averaging $1289.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Lima USA, Inc.$131K
Limacorporate S.p.a.$91K
Techmah Medical, LLC$78K
Pacira Pharmaceuticals Incorporated$53K
Zimmer Biomet$52K
Johnson & Johnson$212
plus $1K from 25 others

$5,000in research payments, 2019–2025

Across 1 payment — averaging $5000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Zimmer Biomet$5K

What the payments were for

Consulting fees$280,31369%
Travel & lodging$63,18716%
Food & beverage$9,0292%
Education$8170%
Ownership interest$52,71313%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Lima USA, Inc.	109	$130,797
Limacorporate S.p.a.	35	$91,372
Techmah Medical, LLC	39	$77,921
Pacira Pharmaceuticals Incorporated	5	$52,713
Zimmer Biomet	68	$51,722
Johnson & Johnson(2 entities)	5	$212
UOC USA Inc	10	$208
Heraeus Medical, LLC.	1	$122
Dynasplint Systems Inc.	2	$94
Convatec Inc.	1	$92
Onkos Surgical, Inc.	3	$80
Stryker	3	$78
Smith+Nephew	3	$58
Protega Pharmaceutials Inc	2	$58
Anika Therapeutics, Inc.	2	$54
Orthofix Medical, Inc.	6	$50
Boston Scientific	2	$49
Illuminoss Medical, Inc.	3	$47
Linvatec Corporation	1	$43
Organogenesis Inc.	2	$40
Heron Therapeutics, Inc.	2	$39
Pacira Therapeutics, Inc.	1	$29
Baxter Healthcare	1	$28
Theragen, Inc.	2	$26
Abbott	1	$25
Nevro Corp.	1	$25
Ferring Pharmaceuticals Inc.	1	$20
Joint Active Systems, Inc.	1	$17
Innovation Technologies Inc	1	$16
Vericel Corporation	1	$15
Aap Implants Inc	1	$9

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$406,058 in reported general payments places this provider in the 95th percentile of 377 orthopaedic surgery providers in Arizona.

See all orthopaedic surgery providers in Arizona →

Medicare billing

Part B allowed, 2024

$165,649

Medicare patients

311

Services billed

1,559

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Oxycodone Hcl	202	$3,983
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	71	$2,019
Celecoxib	84	$1,615
Methylprednisolone	171	$1,029
Ciprofloxacin Hcl	33	$753
Hydromorphone Hcl	26	$572
Prednisone	40	$383
Tramadol Hcl	36	$283
Duloxetine Hcl	14	$268
Cyclobenzaprine Hcl	14	$195
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	21	$179
Furosemide	58	$179
Morphine Sulfate ErMorphine Sulfate	11	$145
Zolpidem Tartrate	12	$111
Gabapentin	19	$86

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Scottsdale

Paul GauseScottsdale$614K
Bertrand KaperScottsdale$482K
David BailieScottsdale$249K
Shane MartinScottsdale$244K
Sherwood DuhonScottsdale$229K
John BradwayScottsdale$219K
Krishna MallikScottsdale$79K
Timothy KavanaughScottsdale$71K
Laura ProkuskiScottsdale$58K
Paul GoodwynScottsdale$56K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →